Abel, EL (1971) Effects of marijuana on the solution of anagrams, memory and appetite. Nature 231, 260–261.
Abel, EL (1975) Cannabis: effects on hunger and thirst. Behavioral Biology 15, 255–281.
Abrahamov, A, Abrahamov, A & Mechoulam, R (1995) An efficient new cannabinoid antiemetic in pediatric oncology. Life Sciences 56, 2097–2102.
Arnone, M, Maruani, J, Chaperon, F, Thiebot, MH, Poncelet, M, Soubrié, P & LeFur, G (1997) Selective inhibition of sucrose and ethanol intake by SR141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology 132, 104–106.
Beal, JE, Olson, R, Laubenstein, L, Morales, JO, Bellman, P, Yangco, B, Lefkowitz, L, Plasse, TF & Shepard, KV (1995) Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. Journal of Pain & Symptom Management 10, 89–97.
Berridge, K (1991) Modulation of taste affect by hunger, energy satiety, and sensory-specific satiety in the rat. Appetite 16, 103–120.
Berridge, K (2000) Measuring hedonic impact in animals and infants: microstructure of affective taste reactivity patterns. Neuroscience and Biobehavioral Reviews 24, 173–198.
Bidaut-Russell, M & Howlett, AC (1991) Cannabinoid receptor regulated cAMP accumulation in the rat striatum. Journal of Neurochemistry 57, 1769–1773.
Bivens, CLM, Thomas, WJ & Stanley, BG (1998) Similar feeding patterns are induced by perifornical neuropeptide Y injection and by food deprivation. Brain Research 782, 271–280.
Breivogel, CS & Childers, SR (1998) The functional neuroanatomy of brain cannabinoid receptors. Neurobiology of Disease 5, 417–431.
Breivogel, CS, Sim, LJ & Childers, SR (1997) Regional differences in cannabinoid receptor/G-protein coupling in rat brain. Journal of Pharmacology and Experimental Therapeutics 282, 1632–1642.
Brown, JE, Kassouny, M & Cross, JK (1977) Kinetic studies of food intake and sucrose solution preference by rats treated with low doses of delta-9-tetrahydrocannabinol. Behavioral Biology 20 104–110.
Burstein, SH, Young, JK & Wright, GE (1995) Relationships between eicosanoids and cannabinoids: are eicosanoids cannabimimetic agents. Biochemical Pharmacology 50, 1735–1742.
Cabeza de Vaca, S & Carr, KD (1998) Food restriction enhances the central rewarding effect of abused drugs. Journal of Neuroscience 18, 7502–7510.
Cat, LK & Coleman, RL (1994) Treatment for HIV wasting syndrome. Annals of Pharmacotherapy 28, 595–597.
Colombo, G, Agabio, R, Diaz, G, Lobina, C, Reali, R & Gessa, GL (1998) Appetite suppression and weight loss after the cannabinoid antagonist SR141716. Life Sciences 63, PL113–PL117.
Clark, JT, Kalra, PS, Crowley, WR & Kalra, SP (1984) Neuropeptide Y and human pancreatic polypeptide stimulate feeding behaviour in rats. Endocrinology 115, 427–429.
Clifton, PJ (2000) Meal patterning in rodents: psychopharmacological and neuroanatomical studies. Neuroscience and Biobehavioral Reviews 24, 213–222.
Cooper, SJ & Clifton, PJ (1996) Drug Receptor Subtypes and Ingestive Behaviour. London: Academic Press.
Cooper, SJ & Kirkham, TC (1993) Opioid mechanisms in the control of food consumption and taste preferences. In Handbook of Experimental Pharmacology, vol. 104, part II, pp. 239–263 [Herz, A, Akil, H & Simon, EJ editors]. Berlin: Springer–Verlag.
Crawley, JN, Corwin, RL, Robinson, JK, Felder, CC, Devane, WA & Axelrod, JA (1993) Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacology Biochemistry and Behavior 46, 967–972.
De Petrocellis, L, Melck, D, Bisogno, T, Milone, A & Di Marzo, V (1999) Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response. Neuroscience 92, 377–387.
Devane, WA, Dysarz, FA, Johnson, MR, Melvin, LS & Howlett, AC (1988) Determination and characterisation of a cannabinoid receptor in rat brain. Molecular Pharmacology 34, 605–613.
Devane, WA, Hanus, L, Breuer, A, Pertwee, RG, Stevenson, LA, Griffin, G, Gibson, D, Mandelbaum, A, Etinger, A & Mechoulam, R (1992) Isolation of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946–1949.
Dewey, WL (1986) Cannabinoid pharmacology. Pharmacological Reviews 38, 151–178.
DiMarzo, V, Bifulco, M & De Petrocellis, L (2000) Endocannabinoids and multiple sclerosis: a blessing from the ‘inner bliss’? Trends in Pharmacological Sciences 21, 195–197.
Di Marzo, V & Deutsch, DG (1998) Biochemistry of endogenous ligands of cannabinoid receptors. Neurobiology of Disease 5, 386–404.
Di Marzo, V, Melck, D, Bisogno, T & De Petrocellis, L (1998) Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends in Neurosciences 21, 521–528.
Drewnowski, A & Grinker, JA (1978) Food and water intake, meal patterns and activity of obese and lean Zucker rats following chronic and acute treatment with Δ9-tetrahydrocannabinol. Pharmacology Biochemistry and Behavior 9, 619–630.
Edwards, CM, Abusnana, S, Sunter, D, Murphy, KG, Ghatei, MA & Bloom, SR (1999) The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. Journal of Endocrinology 160, R7–R12.
Fimiani, C, Liberty, T, Aquirre, AJ, Amin, I, Ali, N & Stefano, GB (1999) Opiate, cannabinoid, and eicosanoid signalling converges on common intracellular pathways nitric oxide coupling. Prostaglandins & Other Lipid Mediators 57, 23–34.
Foltin, RW, Brady, JV & Fischman, MW (1986) Behavioral analysis of marijuana effects on food intake in humans. Pharmacology Biochemistry and Behavior 25, 577–582.
Foltin, RW, Fischman, MW & Byrne, MF (1988) Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory. Appetite 11, 1–14.
Fuentes, JA, Ruiz Gayo, M, Manzanares, J, Vela, G, Reche, I & Corchero, J (1999) Cannabinoids as potential new analgesics. Life Sciences 65, 675–685.
Gallate, JE & McGregor, IS (1999) The motivation for beer in rats: effects of ritanserin, naloxone and SR141716. Psychopharmacology 142, 302–308.
Gallate, JE, Saharov, T, Mallet, PE & McGregor, IS (1999) Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. European Journal of Pharmacology 370, 233–240.
Gaoni, Y & Mechoulam, R (1964) Isolation, structure and partial synthesis of an active constituent of hashish. Journal of the American Chemical Society 86, 1646.
Gardner, EL (1992) Cannabinoid interaction with brain reward systems – the neurobiological basis of cannabinoid abuse. In Marijuana/Cannabinoids: Neurobiology and Neurophysiology, pp. 275–335 [Murphy, LL and Bartke, A editorsC:\cup\Parser]. New York, NY: CRC Press.
Gardner, EL, Paredes, W, Smith, D, Donner, A, Milling, C, Cohen, D & Morrison, D (1988) Facilitation of brain stimulation reward by Δ-9-tetrahydrocannabinol. Psychopharmacology 96, 142–144.
Gardner, EL & Vorel, SR (1998) Cannabinoid transmission and reward-related events. Neurobiology of Disease 5, 502–533.
Glass, M, Dragunow, M & Faull, RLM (1997) Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77, 299–318.
Glick, SD & Milloy, S (1972) Increased and decreased eating following THC administration. Psychonomic Science 29, 6.
Gorter, RW (1999) Cancer cachexia and cannabinoids. Forsch Komplemetarmed 6, Suppl. 3, 21–22.
Gosnell, BA, Krahn, DD & Majchrzak, MJ (1990) The effects of morphine on diet selection are dependent on base-line diet preferences. Pharmacology Biochemistry and Behavior 37, 207–212.
Graceffo, TJ & Robinson, JK (1998) Delta-9-tetrahydrocannabinol (THC) fails to stimulate consumption of a highly palatable food in the rat. Life Sciences 62, 85–88.
Gralla, RJ (1999) Cannabinoids and the control of chemotherapy-induced nausea and vomiting. In Marihuana and Medicine, pp. 599–610 [Nahas, GG, Sutin, KM, Harvey, DJ & Agurell, S editors]. Totowa, NJ: Humana Press.
Greenberg, I, Kuehnle, J, Mendelson, JH & Bernstein, JG (1976) Effects of marijuana use on body weight and energy intake in humans. Psychopharmacology 49, 79–84.
Haines, L & Green, W (1970) Marijuana use patterns. British Journal of Addiction 65, 347–362.
Halikas, JA, Goodwin, DW & Guze, SB (1971) Marijuana effects. A survey of regular users. Journal of the American Medical Association 217, 692–694.
Hampson, AJ, Grimaldi, M, Lolic, M, Wink, D, Rosenthal, R & Axelrod, J (2000) Neuroprotective antioxidants from marijuana. Annals of the New York Academy of Sciences 899, 274–282.
Hao, S, Mechoulam, R & Berry, EM (2000) Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. European Journal of Pharmacology 392, 147–156.
Herkenham, M, Lynn, AB, Little, MD, Johnson, MR, Melvin, LS, De Costa, BR & Rice, KC (1990) Cannabinoid receptor localisation in brain. Proceedings of the National Academy of Sciences USA 87, 1932–1936.
Hoebel, BG (1997) Neuroscience and appetitive behavior research: 25 years. Appetite 29, 119–133.
Hollister, LE (1971) Hunger and appetite after single doses of marijuana, alcohol and dextroamphetamine. Clinical Pharmacology and Therapeutics 14, 45–49.
Hollister, LE (1986) Health aspects of cannabis. Pharmacological Reviews 38, 1–20.
Holst, JJ (1999) Glucagon-like peptide 1 (GLP-1): an intestinal hormone, signalling nutritional abundance, with an unusual therapeutic potential. Trends in Endocrinology and Metabolism 10, 229–235.
Ikemoto, S & Panksepp, J (1999) The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Research Reviews 31, 6–41.
Johnson, SW & North, RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. Journal of Neuroscience 14, 483–488.
Kelley, AE (1999) Functional specificity of ventral striatal compartments in appetitive behaviors. Annals of the New York Academy of Sciences 877, 71–90.
Kirkham, TC (1990) Enhanced anorectic potency of naloxone in rats sham feeding 30% sucrose: reversal by repeated naloxone administration. Physiology and Behavior 47, 419–426.
Kirkham, TC & Cooper, SJ (1988) Naloxone attenuation of sham feeding is modified by manipulation of sucrose concentration. Physiology and Behavior 44, 491–494.
Kirkham, TC & Cooper, SJ (1991) Opioid peptides in relation to the treatment of obesity and bulimia. In Peptides: A Target for New Drug Development, pp. 28–44 [Bloom, SR & Burnstock, G editors]. London: IBC.
Kirkham, TC & Williams, CM (1998) The cannabinoid receptor antagonist SR141716 fails to suppress sucrose sham feeding. Journal of Psychopharmacology 14, Suppl. A, 37.
Kirkham, TC & Williams, CM (1999) Central administration of anandamide induces hyperphagia in satiated rats. Society for Neuroscience Abstracts 25, 1885.
Kirkham, TC & Williams, CM (2001) Synergistic effects of opioid and cannabinoid antagonists on food intake. Psychopharmacology 153, 267–270.
Ledent, C, Valverde, O, Cossu, G, Petite, F, Aubert, J-F, Baslet, F, Bohme, GA, Imperato, A, Pedrazzini, T, Roques, BP, Vassert, G, Fratta, W & Parmentier, M (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283, 401–404.
Leventhal, L, Kirkham, TC, Cole, JL, Bodnar, RJ (1995) Selective actions of central mu and kappa opioid antagonists upon sucrose intake in sham-feeding rats. Brain Research 685, 205–210.
McLaughlin, CL, Baile, CA & Bender, PE (1979) Cannabinols and feeding in sheep. Psychopharmacology 64, 321–323.
Manning, FJ, McDonough, JH, Elsmore, TF, Saller, C & Sodetz, FJ (1971) Inhibition of normal growth by chronic administration of Δ9-tetrahydrocannabinol. Science 174, 424–426.
Marsicano, G & Lutz, B (1999) Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. European Journal of Neuroscience 11, 4213–4225.
Mascia, MS, Obinu, MC, Ledent, C, Parmentier, M, Bohme, GA, Imperato, A & Fratta, W (1999) Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB1 receptor knockout mice. European Journal of Pharmacology 383, R1–R2.
Matsuda, LA, Lolait, SJ, Brownstein, MJ, Young, AC & Bonner, TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561–564.
Mattes, RD, Engelman, K, Shaw, LM & Elsohly, MA (1994) Cannabinoids and appetite stimulation. Pharmacology Biochemistry and Behavior 49, 187–195.
Mechoulam, R, Ben-Shabat, S, Hanus, L, Ligumsky, M, Kaminski, NE, Schatz, AR, Gopher, A, Almog, S, Martin, BR, Compton, DR, Pertwee, RG, Griffin, G, Bayewitch, M, Barg, J & Vogel, Z (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochemical Pharmacology 50, 83–90.
Mechoulam, R, Shani, A, Edery, H & Grunfield, Y (1970) Chemical basis of hashish activity. Science 169, 611.
Mela, DJ & Rogers, PJ (1998) Food Eating and Obesity. London: Chapman and Hall.
Munro, S, Thomas, KL & Abu-Shaar, M (1993) Molecular characterisation of a peripheral receptor for cannabinoids. Nature 365, 61–65.
Nahas, GG, Sutin, KM, Harvey, DJ & Agurell, S (1999) Marihuana and Medicine. Totowa, NJ: Humana Press.
Onaivi, ES, Chakrabarti, A & Chaudhuri, G (1996) Cannabinoid receptor genes. Progress in Neurobiology 48, 275–305.
Pertwee, RG (1995) Cannabinoid Receptors. London: Academic Press.
Pertwee, RG (2000) Neuropharmacology and therapeutic potential of cannabinoids. Addiction Biology 5, 37–46.
Piomelli, D, Beltramo, M, Giuffrida, A & Stella, N (1998) Endogenous cannabinoid signaling. Neurobiology of Disease 5, 462–473.
Plasse, TF, Gorter, RW, Krasnow, SH, Lane, M, Shepard, KY & Wadleigh, RG (1991) Recent clinical experience with dronabinol. Pharmacology Biochemistry and Behavior 40, 695–700.
Regelson, W, Butler, JR & Schultz, J (1976) Delta-9-tetrahydrocannabinol as an effective antidepressant and appetite-stimulating agent in advanced cancer patients. In The Pharmacology of Marijuana, pp. 763–776 [Braude, MC & Szara, S editors]. New York, NY: Raven Press.
Reggio, PH (1999) Cannabinoid receptors. Tocris Reviews 10, 1–5.
Rodriguez de Fonseca, F, Martinz Calderon, JL, Mechoulam, R & Navarro, M (1994) Repeated stimulation of D1 dopamine receptors enhances (2)-11-hydroxy-delta-8-tetrahydrocannabinol-dimethyl-heptyl-induced catalepsy in male rats. Neuroreport 5, 761–765.
Rodriguez de Fonseca, F, Roberts, AJ, Bilbao, A, Koob, GF & Navarro, M (1999) Cannabinoid receptor antagonist SR141716 decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers. Acta Pharmacologica Sinica 20, 1109–1114.
Sacks, N, Hutcheson, JR, Watts, JM & Webb, RE (1990) Case report: the effect of tetrahydrocannabinol on food intake during chemotherapy. Journal of the American College of Nutrition 9, 630–632.
Sanudo-Pena, MC, Patrick, SL, Patrick, RL & Walker, JM (1996) Effects of intranigral cannabinoids on rotational behaviour in rats: Interaction with the dopaminergic system. Neuroscience Letters 206, 21–24.
Schwartz, MW, Woods, SC, Porte, D Jr, Seeley, RJ & Baskin, DG (2000) Central nervous system control of food intake. Nature 404, 661–671.
Simiand, J, Keane, M, Keane, PE & Soubrie, P (1998) SR141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behavioural Pharmacology 9, 179–181.
Sjoden, P-O, Jarbe, TUC & Henriksson, BG (1973) Influence of tetrahydrocannabinols (Δ-8-THC and Δ-9-THC) on body weight, food and water intake in rats. Pharmacology Biochemistry and Behavior 1, 395–399.
Soderstrom, K, Leid, M, Moore, FL & Murray, TF (2000) Behavioral, pharmacological, and molecular characterization of an amphibian cannabinoid receptor. Journal of Neurochemistry 75, 413–423.
Sofia, RD & Barry, H (1974) Acute and chronic effects of Δ-9-tetrahydrocannabinol on food intake by rats. Psychopharmacologia 39, 213–222.
Souilhac, J, Poncelet, M, Rinaldi-Carmona, M, Le Fur, G & Soubrie, P (1995) Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice. Pharmacology Biochemistry and Behavior 51, 3–7.
Spanagel, R & Weiss, F (1999) The dopamine hypothesis of reward: past and current status. Trends in Neurosciences 22, 521–527.
Stella, N, Schweitzer, P & Piomelli, D (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388, 773–778.
Stratford, TR, Swanson, CJ & Kelley, A (1998) Specific changes in food intake elicited by blockade or activation of glutamate receptors in the nucleus accumbens shell. Behavioral Brain Research 93, 43–50.
Stuwe, M, Kaempfer, SH, Geiger, CJ, Pavia, AT, Plasse, TF, Shepard, KV, Ries, K & Evans, TG (1993) Effect of dronabinol on nutritional status in HIV infection. Annals of Pharmacotherapy 27, 827–831.
Tanda, G, Pontieri, FE & DiChiara, G (1997) Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common μ1 opioid receptor mechanism. Science 276, 2048–2050.
Tart, C (1970) Marijuana intoxication: common experiences. Nature 226, 701–704.
Trojniar, W & Wise, RA (1991) Facilitory effect of Δ-9-tetrahydrocannabinol on hypothalamically-induced feeding. Psychopharmacology 103, 172–176.
Volicer, L (1997) Dronabinol may help behaviour problems in Alzheimers disease. American Family Physician 55, 1338.
Weingarten, HP & Watson, SD (1982) Sham feeding as a procedure for assessing the influence of diet palatability on food intake. Physiology and Behavior 28, 401–407.
Welch, SP & Eads, EM (1999) Synergistic interactions of endogenous opioids and cannabinoid systems. Brain Research 848, 183–190.
Williams, CM, Rogers, PJ & Kirkham, TC (1998) Hyperphagia in pre-fed rats following oral Δ-9-THC. Physiology and Behavior 65, 343–346.
Williams, CM & Kirkham, TC (1999 a) Anandamide induces overeating: mediation by central cannabinoid receptors. Psychopharmacology 143, 315–317.
Williams, CM & Kirkham, TC (1999 b). Observational analysis of Δ9-THC effects on feeding microstructure in rats. Journal of Psychopharmacology 13 (3, Suppl. A), 20.